Prelude Capital Management’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-5,136
Closed -$366K 1344
2026
Q1
$366K Buy
+5,136
New +$405K 0.03% 630
2025
Q2
Sell
-8,190
Closed -$661K 1119
2025
Q1
$661K Buy
+8,190
New +$704K 0.05% 422

Other funds holding GEHC

Prelude Capital Management's GEHC Position: Q2 2026 in Review

Prelude Capital Management sold out of GE HealthCare (GEHC) in Q2 2026, closing a stake of 5,136 shares — an estimated $366K sold.

Prelude Capital Management first reported a position in GEHC in Q1 2025 and held it in 2 quarters. The position peaked at $661K in Q1 2025. 1,223 funds tracked by Wall St. Rank hold GEHC as of Q2 2026.

  • Prelude Capital Management reported no remaining GE HealthCare position as of Q2 2026 after selling out during the quarter.
  • Prelude Capital Management sold 5,136 GE HealthCare shares in Q2 2026, an estimated $366K.
  • Prelude Capital Management first reported a position in GE HealthCare in Q1 2025 and held it in 2 quarters.
  • Prelude Capital Management's GE HealthCare position peaked at $661K in Q1 2025.
  • 1,223 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2026.

Based on Prelude Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.